Rilmazafone hydrochloride

This classification denotes a sedative and hypnotic with the molecular structure C21H20CL2N6O3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 25T258X8BV chemically known as 5-(((2-aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-n,n-dimethyl-1h-1,2,4-triazole-3-carboxamide hydrochloride, but more commonly known as rilmazafone hydrochloride, which bears US NIH Compound Identifier 135366. European Medicines Agency schedules Rilmazafone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22078. Most nations, for tariff and trade purposes, schedule rilmazafone hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, RILMAZAFONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)C(=O)C1NC(N(N1)C2CCC(CC2C(=O)C3CCCCC3CL)CL)CNC(=O)CN.CL.